LAM
GILD icon

Lakewood Asset Management’s Gilead Sciences GILD Stock Holding History

Lakewood Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,317
Closed -$609K – 121
2024
Q1 		$609K Buy
8,317
+1,298
+18% +$99.8K 0.41% 63
2023
Q4 		$569K Sell
7,019
-558
-7% -$43.4K 0.44% 58
2023
Q3 		$568K Sell
7,577
-15
-0.2% -$1.15K 0.46% 57
2023
Q2 		$585K Buy
7,592
+29
+0.4% +$2.31K 0.46% 59
2023
Q1 		$627K Buy
7,563
+28
+0.4% +$2.32K 0.52% 55
2022
Q4 		$647K Buy
+7,535
New +$597K 0.52% 55

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lakewood Asset Management's GILD Position: Q2 2024 in Review

Lakewood Asset Management sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 8,317 shares — an estimated $609K sold.

Lakewood Asset Management first reported a position in GILD in Q4 2022 and held it in 6 quarters. The position peaked at $647K in Q4 2022. 1,679 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • Lakewood Asset Management reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
  • Lakewood Asset Management sold 8,317 Gilead Sciences shares in Q2 2024, an estimated $609K.
  • Lakewood Asset Management first reported a position in Gilead Sciences in Q4 2022 and held it in 6 quarters.
  • Lakewood Asset Management's Gilead Sciences position peaked at $647K in Q4 2022.
  • 1,679 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Lakewood Asset Management's 13F filing for Q2 2024, filed 18 Jul 2024.